vs
Side-by-side financial comparison of Invesco Mortgage Capital Inc. (IVR) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
Invesco Mortgage Capital Inc. is the larger business by last-quarter revenue ($21.3M vs $18.3M, roughly 1.2× ROCKWELL MEDICAL, INC.). Invesco Mortgage Capital Inc. runs the higher net margin — 242.2% vs -3.0%, a 245.3% gap on every dollar of revenue. On growth, Invesco Mortgage Capital Inc. posted the faster year-over-year revenue change (55.4% vs -25.6%). Over the past eight quarters, Invesco Mortgage Capital Inc.'s revenue compounded faster (74.2% CAGR vs -10.1%).
Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
IVR vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.3M | $18.3M |
| Net Profit | $51.5M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | — | -2.2% |
| Net Margin | 242.2% | -3.0% |
| Revenue YoY | 55.4% | -25.6% |
| Net Profit YoY | 1368.7% | 26.7% |
| EPS (diluted) | $0.72 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.3M | $18.3M | ||
| Q3 25 | $17.6M | $15.9M | ||
| Q2 25 | $17.7M | $16.1M | ||
| Q1 25 | $18.8M | $18.9M | ||
| Q4 24 | $13.7M | $24.7M | ||
| Q3 24 | $7.5M | $28.3M | ||
| Q2 24 | $8.6M | $25.8M | ||
| Q1 24 | $7.0M | $22.7M |
| Q4 25 | $51.5M | $-554.0K | ||
| Q3 25 | $53.5M | $-1.8M | ||
| Q2 25 | $-23.3M | $-1.5M | ||
| Q1 25 | $19.6M | $-1.5M | ||
| Q4 24 | $3.5M | $-756.0K | ||
| Q3 24 | $40.7M | $1.7M | ||
| Q2 24 | $-13.5M | $343.0K | ||
| Q1 24 | $29.1M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | -2.2% | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | — | -8.4% | ||
| Q1 25 | — | -7.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | -5.8% |
| Q4 25 | 242.2% | -3.0% | ||
| Q3 25 | 303.6% | -11.0% | ||
| Q2 25 | -131.6% | -9.3% | ||
| Q1 25 | 104.4% | -8.0% | ||
| Q4 24 | 25.6% | -3.1% | ||
| Q3 24 | 542.2% | 5.9% | ||
| Q2 24 | -155.9% | 1.3% | ||
| Q1 24 | 415.9% | -7.6% |
| Q4 25 | $0.72 | $-0.01 | ||
| Q3 25 | $0.74 | $-0.05 | ||
| Q2 25 | $-0.40 | $-0.05 | ||
| Q1 25 | $0.26 | $-0.04 | ||
| Q4 24 | $-0.09 | $-0.02 | ||
| Q3 24 | $0.63 | $0.04 | ||
| Q2 24 | $-0.38 | $0.01 | ||
| Q1 24 | $0.49 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $56.0M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $797.5M | $37.0M |
| Total Assets | $6.5B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $56.0M | $10.7M | ||
| Q3 25 | $58.5M | $13.6M | ||
| Q2 25 | $59.4M | $12.5M | ||
| Q1 25 | $42.9M | $11.4M | ||
| Q4 24 | $73.4M | $15.7M | ||
| Q3 24 | $48.3M | $12.3M | ||
| Q2 24 | $58.8M | $11.9M | ||
| Q1 24 | $59.9M | $6.6M |
| Q4 25 | $797.5M | $37.0M | ||
| Q3 25 | $769.6M | $37.0M | ||
| Q2 25 | $709.4M | $30.4M | ||
| Q1 25 | $759.2M | $31.5M | ||
| Q4 24 | $730.7M | $32.6M | ||
| Q3 24 | $857.0M | $29.1M | ||
| Q2 24 | $759.2M | $23.5M | ||
| Q1 24 | $785.6M | $20.6M |
| Q4 25 | $6.5B | $57.1M | ||
| Q3 25 | $6.0B | $57.5M | ||
| Q2 25 | $5.4B | $52.6M | ||
| Q1 25 | $6.2B | $54.0M | ||
| Q4 24 | $5.7B | $59.2M | ||
| Q3 24 | $6.1B | $57.1M | ||
| Q2 24 | $5.1B | $53.0M | ||
| Q1 24 | $5.2B | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $157.1M | $2.3M |
| Free Cash FlowOCF − Capex | — | $2.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | 3.05× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $157.1M | $2.3M | ||
| Q3 25 | $37.3M | $-1.3M | ||
| Q2 25 | $40.6M | $1.8M | ||
| Q1 25 | $19.3M | $-3.5M | ||
| Q4 24 | $183.2M | $865.0K | ||
| Q3 24 | $30.8M | $4.3M | ||
| Q2 24 | $33.0M | $1.4M | ||
| Q1 24 | $57.5M | $-2.4M |
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-2.5M |
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% | ||
| Q1 24 | — | -11.1% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 3.05× | — | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 52.24× | — | ||
| Q3 24 | 0.76× | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | 1.97× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IVR
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
